202 related articles for article (PubMed ID: 32833021)
61. Epidemiology and burden of HPV-related disease.
Serrano B; Brotons M; Bosch FX; Bruni L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
[TBL] [Abstract][Full Text] [Related]
62. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
63. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
64. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
65. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
66. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
67. Declining awareness of HPV and HPV vaccine within the general US population.
Chido-Amajuoyi OG; Jackson I; Yu R; Shete S
Hum Vaccin Immunother; 2021 Feb; 17(2):420-427. PubMed ID: 32692632
[TBL] [Abstract][Full Text] [Related]
68. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
[TBL] [Abstract][Full Text] [Related]
69. Indications and efficacy of the human papillomavirus vaccine.
Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
[TBL] [Abstract][Full Text] [Related]
70. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
71. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.
Mullins TL; Wilson CM; Rudy BJ; Sucharew H; Kahn JA
Sex Transm Dis; 2013 Sep; 40(9):715-20. PubMed ID: 23949587
[TBL] [Abstract][Full Text] [Related]
72. Oropharyngeal Carcinomas Strongly Associated with Human Papillomavirus: Incidence Trends in the Elderly US Population Using SEER vs US Cancer Statistics Databases.
Polednak AP
J Registry Manag; 2018; 45(2):65-71. PubMed ID: 31533129
[TBL] [Abstract][Full Text] [Related]
73. State of the Science: Screening, Surveillance, and Epidemiology of HPV-Related Malignancies.
Ghebre R; Berry-Lawhorn JM; D'Souza G
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-12. PubMed ID: 33830827
[TBL] [Abstract][Full Text] [Related]
74. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.
Hessol NA; Holly EA; Efird JT; Minkoff H; Weber KM; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
AIDS; 2013 Jul; 27(11):1743-51. PubMed ID: 23803793
[TBL] [Abstract][Full Text] [Related]
75. Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence.
Nailescu C; Ermel AC; Shew ML
Pediatr Transplant; 2022 Nov; 26(7):e14341. PubMed ID: 35808949
[TBL] [Abstract][Full Text] [Related]
76. Trends in the incidence of human papillomavirus-related noncervical and cervical cancers in Alberta, Canada: a population-based study.
Shack L; Lau HY; Huang L; Doll C; Hao D
CMAJ Open; 2014 Jul; 2(3):E127-32. PubMed ID: 25114894
[TBL] [Abstract][Full Text] [Related]
77. Human Papillomavirus: One Less Worry for Men Too?
Elst L; Albersen M
Eur Urol; 2022 Jun; 81(6):549-551. PubMed ID: 35346517
[TBL] [Abstract][Full Text] [Related]
78. Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
Nierengarten MB
Cancer; 2021 Oct; 127(19):3499. PubMed ID: 34478157
[No Abstract] [Full Text] [Related]
79. Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients.
Chaussade H; Le Marec F; Coureau G; Leleux O; Neau D; Lazaro E; Amadeo B; Duffau P; Ferrand H; Courtault C; Foucan AS; Wittkop L; Bonnet F
AIDS; 2022 Apr; 36(5):665-673. PubMed ID: 34923517
[TBL] [Abstract][Full Text] [Related]
80. Human Papillomavirus (HPV)-Associated Cancers Among Hispanic Males in the United States: Late-Stage Diagnosis by Country of Origin.
Villalona S; Villalona S; Reinoso D; Sukhdeo S; Stroup AM; Ferrante JM
Cancer Control; 2023; 30():10732748231218088. PubMed ID: 38015627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
